Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mitochondrial Disease.

Roser Pons1, Darryl C. De Vivo

  • 1Departments of Neurology and Pediatrics, Columbia University College of Physicians and Surgeons, 710 West 168th Street, New York, NY 10032, USA. dcd1@columbia.edu

Current Treatment Options in Neurology
|April 3, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cognitive and Psychosocial Burden of Childhood Cancer Survivors in Greece: A Case-Control Study.

Medical sciences (Basel, Switzerland)·2026
Same author

International Registry of NKX2-1-Related Disorders: Clinical, Genetic, and Imaging Perspectives.

Movement disorders : official journal of the Movement Disorder Society·2026
Same author

Tasks for Assessing Dystonia in Young People With Cerebral Palsy.

Pediatric neurology·2025
Same author

Consensus Guideline for the Diagnosis and Treatment of Tyrosine Hydroxylase (TH) Deficiency.

Journal of inherited metabolic disease·2025
Same author

"Tuberous sclerosis in Greece: A national cohort study on clinical features and rare manifestations".

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society·2025
Same author

Tasks for assessing dystonia in young people with cerebral palsy.

medRxiv : the preprint server for health sciences·2025
Same journal

Visual Impairment and Driving in Older Adults: A Narrative Review.

Current treatment options in neurology·2026
Same journal

Non-Cognitive Symptoms in Alzheimer's Disease and Their Likely Impact on Patient Outcomes. A Scoping Review.

Current treatment options in neurology·2026
Same journal

Update on the Treatment of Autonomic Disorders.

Current treatment options in neurology·2025
Same journal

Primary Progressive Aphasia Treatment: Current Treatment Options in Neurology Article Topic: Management of Primary Progressive Aphasia.

Current treatment options in neurology·2025
Same journal

Emerging Principles for Treating Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD).

Current treatment options in neurology·2025
Same journal

Diagnosis and Management of Progressive Corticobasal Syndrome.

Current treatment options in neurology·2025
See all related articles

Mitochondrial diseases, affecting energy metabolism, have disappointing treatments for pyruvate, Krebs cycle, and respiratory chain defects. Fatty acid oxidation disorders show better outcomes with diet and supplements like L-carnitine.

Area of Science:

  • Biochemistry
  • Genetics
  • Metabolic Disorders

Background:

  • Mitochondrial diseases disrupt cellular energy metabolism, impacting pyruvate metabolism, Krebs cycle, respiratory chain (RC), and fatty acid oxidation (FAO).
  • Current treatments for pyruvate, Krebs cycle, and RC disorders yield poor results, relying on unproven supportive therapies.
  • Fatty acid oxidation (FAO) disorders have more effective management strategies.

Purpose of the Study:

  • To review current therapeutic approaches for various mitochondrial energy metabolism disorders.
  • To highlight the need for rigorous clinical trials in rare and heterogeneous mitochondrial diseases.
  • To emphasize the importance of consensus in managing patients with mitochondrial disorders.

Main Methods:

  • Literature review of existing treatment strategies and clinical trial data.

Related Experiment Videos

  • Analysis of therapeutic outcomes for different types of mitochondrial energy metabolism defects.
  • Identification of key areas for future research and clinical management.

    • Main Results:

    • Treatments for pyruvate metabolism, Krebs cycle, and RC disorders are generally ineffective.
    • Dietary management, L-carnitine, and riboflavin are effective for FAO disorders.
    • Supplementation of L-carnitine, coenzyme Q(10), and vitamins can be curative for specific deficiencies.

    Conclusions:

    • Well-designed clinical trials are crucial for advancing treatment efficacy in rare mitochondrial diseases.
    • A consensus on patient management is needed while awaiting more specific therapies.
    • Stabilization of the clinical condition is the primary goal of current interventions for mitochondrial disorders.